THE final version of the Review of the Efficient Funding of Chemotherapy (EFC) Funding Arrangements has been received by The Department of Health and Aged Care.
Included in the final report is an examination of the impact and continued sustainability of the current EFC Program and associated practices across the cancer medicines supply chain.
It was created with the aid of 29 submissions representing 32 contributing organisations and individual stakeholders received after the release of the interim report in Sep 2022.
One such finding was an insufficient basis to support changes to the current EFC fees, while additional fee components could be considered in the long-term to address changes in pharmacy practices to minimise waste.
The full report is available to read here.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 23
